Statin Use and the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B,Hepatology

当前位置： X-MOL 学术 › Hepatology › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Statin Use and the Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B
Hepatology ( IF 12.9 ) Pub Date : 2020-02-14 , DOI: 10.1002/hep.30973
Myung Ji Goh ₁ , Dong Hyun Sinn ₁ , Seonwoo Kim ₂ , Sook Young Woo ₂ , Hyun Cho ₂ , Wonseok Kang ₁ , Geum-Youn Gwak ₁ , Yong-Han Paik ₁ , Moon Seok Choi ₁ , Joon Hyeok Lee ₁ , Kwang Cheol Koh ₁ , Seung Woon Paik ₁

Affiliation

Statins have pleiotropic effects that may include chemoprevention. Several observational studies have suggested that statins may prevent hepatocellular carcinoma (HCC), but they have not yet been fully studied in patients with chronic hepatitis B virus (HBV) infections.

中文翻译：